Uterine Cancer Study Act of 2024

Hozzl · 2024-10-09T01:38:18Z

Explore the details of House Bill 9782 Uterine Cancer Study Act of 2024 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

10/9/2024, 1:38 AM

Summary of Bill HR 9782

The Uterine Cancer Study Act of 2024, designated as H.R. 9782 in the 118th Congress and introduced on September 24, 2024, aims to authorize a study focused on uterine cancer. The bill does not provide specific provisions or directives beyond this purpose. For more details, the official PDF version of the bill can be accessed at https://www.congress.gov/118/bills/hr9782/BILLS-118hr9782ih.pdf.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 9782

Bill HR 9782 is currently in the status of Bill Introduced since September 24, 2024. Bill HR 9782 was introduced during Congress 118 and was introduced to the House on September 24, 2024. Bill HR 9782's most recent activity was Referred to the House Committee on Energy and Commerce. as of September 24, 2024

Bipartisan Support of Bill HR 9782

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 9782

Primary Policy Focus

Alternate Title(s) of Bill HR 9782

Uterine Cancer Study Act of 2024

To direct the Secretary of Health and Human Services to study and report on the relationship between hair straighteners and uterine cancer, particularly among women of color.